Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. Design Randomised double blind (clinician, patient, outcomes assessor) placebo...

Celý popis

Podrobná bibliografie

Vydáno v:	BMJ
Hlavní autoři:	Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare, Lee, Lesley, Bannister, Carol, Elvish, Ruth, Jacoby, Robin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2005
Témata:	Papers
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC556156/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15722369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38369.459988.8F
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!